Skip to main content
TipRanks
Go Ultimate75% OFF

Accendra Health (ACH) Stock Statistics & Valuation Metrics

570 Followers

Total Valuation

Accendra Health has a market cap or net worth of $10.16M. The enterprise value is $1.87B.

Market Cap
$10.16M
Enterprise Value
$1.87B

Share Statistics

Accendra Health has 76,965,324 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
76,965,324
Owned by Insiders
3.80%
Owned by Institutions
47.31%

Financial Efficiency

Accendra Health’s return on equity (ROE) is 2.39 and return on invested capital (ROIC) is 12.33%.

Return on Equity (ROE)
2.39
Return on Assets (ROA)
-0.45
Return on Invested Capital (ROIC)
12.33%
Return on Capital Employed (ROCE)
0.15
Revenue Per Employee
424.93K
Profits Per Employee
-169.33K
Employee Count
6,500
Asset Turnover
1.13
Inventory Turnover
19.79

Valuation Ratios

The current PE Ratio of Accendra Health is -0.06. Accendra Health’s PEG ratio is -0.00.

PE Ratio
-0.06
PS Ratio
0.00
PB Ratio
-0.02
Price to FCF
-0.06
Price to Operating Cash Flow
-0.40
PEG Ratio
-0.00

Income Statement

In the last 12 months, Accendra Health had revenue of 2.76B and earned -1.10B in profits. Earnings per share was -14.31.

Revenue
2.76B
Gross Profit
1.29B
Operating Income
221.74M
Pretax Income
-101.95M
Net Income
-1.10B
EBITDA
219.75M
Earnings Per Share (EPS)
-14.31

Cash Flow

In the last 12 months, operating cash flow was -25.31M and capital expenditures -138.52M, giving a free cash flow of -163.83M billion.

Operating Cash Flow
-25.31M
Free Cash Flow
-163.83M
Free Cash Flow per Share
-2.13

Dividends & Yields

Accendra Health pays an annual dividend of $0.00, resulting in a dividend yield of ―

Dividend Per Share
$0.00
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-1613.89%
Earnings Yield
-1689.94%

Stock Price Statistics

Beta
1.35
52-Week Price Change
-95.49%
50-Day Moving Average
0.53
200-Day Moving Average
2.15
Relative Strength Index (RSI)
24.10
Average Volume (3m)
2.46M

Important Dates

Accendra Health upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Feb 24, 2027
Ex-Dividend Date
Dec 14, 2021

Financial Position

Accendra Health as a current ratio of 0.58, with Debt / Equity ratio of -484.57%

Current Ratio
0.58
Quick Ratio
0.50
Debt to Market Cap
10.05
Net Debt to EBITDA
8.88
Interest Coverage Ratio
2.07

Taxes

In the past 12 months, Accendra Health has paid 729.00K in taxes.

Income Tax
729.00K
Effective Tax Rate
-0.01

Enterprise Valuation

Accendra Health EV to EBITDA ratio is 13.01, with an EV/FCF ratio of -11.20.

EV to Sales
0.72
EV to EBITDA
13.01
EV to Free Cash Flow
-11.20
EV to Operating Cash Flow
-72.51

Balance Sheet

Accendra Health has $26.61M in cash and marketable securities with $1.85B in debt, giving a net cash position of -$1.82B billion.

Cash & Marketable Securities
$26.61M
Total Debt
$1.85B
Net Cash
-$1.82B
Net Cash Per Share
-$23.71
Tangible Book Value Per Share
-$24.31

Margins

Gross margin is 44.13%, with operating margin of 1.60%, and net profit margin of -6.72%.

Gross Margin
44.13%
Operating Margin
1.60%
Pretax Margin
-5.83%
Net Profit Margin
-6.72%
EBITDA Margin
5.53%
EBIT Margin
-0.64%

Analyst Forecast

The average price target for Accendra Health is $0.25, which is 11.43% higher than the current price. The consensus rating is Neutral

Price Target
$0.25
Price Target Upside
89.39% Upside
Analyst Consensus
Neutral
Analyst Count
2
Revenue Growth Forecast
-61.96%
EPS Growth Forecast
87.15%

Scores

Smart Score
―
AI Score
40